Biotech companies can now take samples from their production as often as they wish, untouched by human hands. Both the company and product were nurtured in the Biopro network, which involves a number of Danish biotech companies and DTU and the University of Copenhagen.
“We were recently in contact with a foreign food industry company which told us that it takes approx. 12,000 samples annually from its production, at one factory alone. Everything is done manually today.”
“Through the Biopro network, we have had the opportunity to get into the inner sanctum of these companies. It is a great advantage that our product has been tested on real production data and not just simulations.”
Faulty samples can be expensive In recent years, many food and pharmaceutical companies have begun to switch from batch production to continuous production.
“We want to add modules which analyse the samples using near-infrared light or other methods. The types of add-on analyses desired will no doubt vary from company to company. They will give companies access to regular information about core parameters in production. This will open up new opportunities for optimizing processes along the way,” says Christian Lysholm.
“We were recently in contact with a foreign food industry company which told us that it takes approx. 12,000 samples annually from its production, at one factory alone. Everything is done manually today,” says Christian Lysholm.